Brand: Jelfa
Omnadren® 250 is an injectable testosterone blend made by Jelfa S.A., a Polish pharmaceutical company. Each 1 mL ampoule holds 250 mg of mixed testosterone esters in oil. It's often called a four-component testosterone, and that fits. The product is still testosterone. The esters only decide how quickly the body receives it. A blend gives a fast start and a long tail from a single injection, which is why products like this are used in hormone replacement and discussed so often in strength-training circles. Omnadren belongs to the same family as Sustanon 250, so the two are usually compared side by side.
Omnadren® 250 combines four testosterone esters in an oil base. Testosterone propionate (30 mg) is the fastest and starts working within about a day. Testosterone phenylpropionate (60 mg) takes over as propionate fades, and testosterone isocaproate (60 mg) bridges the middle phase. Testosterone decanoate (100 mg) is the slowest and carries the effect out to about three weeks. After absorption, the body removes each ester and releases active testosterone. Some older references list a caproate ester in place of decanoate, so the exact mix can vary by batch or version.
It is an injectable testosterone blend from Jelfa S.A., Poland. Each 1 mL contains 250 mg of four mixed testosterone esters.
They are very close. Both are four-ester testosterone blends with a similar mix and similar timing. The main differences are the manufacturer and the formulation.
A blend gives a quick start and a long release from one injection. A single ester gives only one of those.
No. It is not an FDA-approved product in the United States. Testosterone is approved for specific medical uses, such as treating diagnosed testosterone deficiency, under prescription. Non-medical use is not approved.
No. Non-prescribed use is regulated or prohibited in most countries.
Explore trusted products, clear information and support for your fitness journey.
Subscribe Now
Log in to track orders and check out faster.
lock Your details are encrypted and never shared.
